Diagnos Inc. logo

Diagnos Inc. (4D4A)

Market Closed
12 Dec, 20:00
XFRA XFRA
0. 18
0
0%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0 Eps
0.18
Previous Close
Day Range
0.18 0.18
Year Range
0.1 0.24
Want to track 4D4A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 1 days

Summary

4D4A closed yesterday higher at €0.18, an increase of 0% from Thursday's close, completing a monthly decrease of -3.14% or €0.01. Over the past 12 months, 4D4A stock gained 3.35%.
4D4A is not paying dividends to its shareholders.
The last earnings report, released on Dec 11, 2025, exceeded the consensus estimates by 0.01%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports. The next scheduled earnings report is due on Dec 15, 2025.
Diagnos Inc. has completed 1 stock splits, with the recent split occurring on Apr 24, 2019.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).

4D4A Chart

Diagnos Inc. (4D4A) FAQ

What is the stock price today?

The current price is €0.18.

On which exchange is it traded?

Diagnos Inc. is listed on TSX-V.

What is its stock symbol?

The ticker symbol is 4D4A.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Dec 15, 2025.

Has Diagnos Inc. ever had a stock split?

Diagnos Inc. had 1 splits and the recent split was on Apr 24, 2019.

Diagnos Inc. Profile

Insurance Industry
Financials Sector
Mr. Andre Larente CEO
XFRA Exchange
CA2524423068 ISIN
US Country
- Employees
- Last Dividend
24 Apr 2019 Last Split
- IPO Date

Overview

DIAGNOS Inc. is a dynamic company offering advanced software-based services with a primary focus on the healthcare sector. With a corporate footprint that extends beyond Canada to the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica, DIAGNOS stands as a global entity dedicated to leveraging technology for health improvement. Founded in 1998 and with its headquarters in Brossard, Canada, the company has harnessed the power of data analysis and artificial intelligence to offer cutting-edge solutions. DIAGNOS Inc. is recognized for its innovative approach to medical diagnostics and consulting services, making significant contributions to the fields it operates in.

Products and Services

  • Computer Assisted Retina Analysis (CARA)
  • DIAGNOS Inc.'s flagship product, CARA, is a web-based software tool designed to revolutionize the way healthcare professionals detect diabetic retinopathy. This condition, a major complication of diabetes, can lead to significant visual impairment if not detected and treated in time. CARA supports eye care specialists by offering a platform for the visualization of both normal and pathological changes within the retina, facilitating early detection and management of this disease.

  • Consulting Services
  • Beyond its software offerings, DIAGNOS extends its expertise through a range of consulting services concentrated in data analysis and the application of artificial intelligence. These services are tailored to help businesses and healthcare entities navigate the complexities of data interpretation, decision-making processes, and the implementation of AI-driven solutions. Through personalized consulting, DIAGNOS empowers its clients to achieve their strategic objectives by leveraging the power of advanced analytics and artificial intelligence.

Contact Information

Address: 7005 Taschereau Boulevard, Brossard, QC, Canada, J4Z 1A7
Phone: 450 678 8882